Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.
<h4>Background</h4>Although the 2009 (H1N1) influenza pandemic officially ended in August 2010, the virus will probably circulate in future years. Several types of H1N1 vaccines have been tested including various dosages and adjuvants, and meta-analysis is needed to identify the best for...
Guardado en:
Autores principales: | Lamberto Manzoli, Corrado De Vito, Georgia Salanti, Maddalena D'Addario, Paolo Villari, John P A Ioannidis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/213ef079bf3a4fc5a4d0661ab9741322 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals.
por: Heimo Lagler, et al.
Publicado: (2012) -
Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients.
por: João L Miraglia, et al.
Publicado: (2011) -
IMMUNOGENICITY OF ADJUVANT INFLUENZA VACCINE FOR PREGNANT WOMEN
por: M. P. Kostinov, et al.
Publicado: (2017) -
Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
por: Lisa A Prosser, et al.
Publicado: (2011) -
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.
por: Otfried Kistner, et al.
Publicado: (2010)